Newborn Sequencing Research

With the latest advancements in next generation sequencing (NGS), we are experiencing rapid acceleration in genetic disease research and neonatal research. While NGS maintains the power to detect genetic variants responsible for many diseases, these technologies have been inaccessible for many laboratories.

Through our decades of experience in rare disease technologies, Revvity has developed an end-to-end neonatal sequencing workflow to suit your needs. Our configurable, holistic workflow – from the DNA extraction of dried blood spot samples, library preparation, automated liquid handling, sequencing, to final data analysis – is built to bring newborn genome sequencing into the hands of more laboratories. One end-to-end solution, all from one supplier who specializes in newborn DNA analysis.

Download brochure Learn more

For research use only. Not for use in diagnostic procedures.

Benefits for your laboratory

Workflow steps

From sample to final result, we cover the entire sequencing process.

Targeted sequencing vs. WGS

While our workflow supports both WGS and targeted sequencing, we recommend targeted as the optimal starting point. This approach has fewer data security concerns, storage requirements and brings added simplicity to data assessment. Reach out to us to determine which method is best for you.

Newborn sequencing lab services

As an alternative to adopting our solution, you may choose to consider outsourcing the workflow through Revvity Omics – our global network of laboratories. Comprised of the same instrumentation and trusted internationally, see how you can leverage our genomic technologies with Revvity Omics today.

Learn more